[D-Penicillamin for treatment of sarcoidosis (author's transl)].
The pharmacological qualities of the D-Penicillamin and the data of immunology and especially of the collagenous metabolism of the sarcoidosis justify an investigation of the therapeutical effect of D-Penicillamin. An account is given of six patients who were suffering from sarcoidosis and of whom an effective influence over the X-ray findings was stated after a three months' dose at least. It seems to be a continuous success because after a one-to-three years' obse-vation a relapse has not occurred.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010396:Penicillamine / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D012507:Sarcoidosis / Q000188:drug therapy*; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D010396:Penicillamine
D-Penicillamin in der Behandlung der Sarkoidose.